Dissemin is shutting down on January 1st, 2025

Published in

F1000Research, F1000Research, (8), p. 750, 2019

DOI: 10.12688/f1000research.18800.2

F1000Research, F1000Research, (8), p. 750, 2019

DOI: 10.12688/f1000research.18800.1

Links

Tools

Export citation

Search in Google Scholar

Human respiratory syncytial virus methyl transferase: a potential antiviral target?

Journal article published in 2019 by Raj Kalkeri ORCID, Govinda Bhisetti, Nagraj Mani
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Red circle
Preprint: archiving forbidden
Red circle
Postprint: archiving forbidden
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO

Abstract

Human respiratory syncytial virus (HRSV) causes bronchiolitis and pneumonia. The role of methyltransferase (MTase) activity of HRSV polymerase in viral replication is unknown. Literature reviews of similar viral MTases and homology- modeling of RSV MTase bound to GTP and S-adenosylmethionine (SAM) have shown sequence similarity and the conserved catalytic residues (K-D-K-E) and the SAM-binding (GXGXG) domain. Combined with the recent reports of the importance of 2’O methylation of viral RNAs in the host innate immune response evasion, and its proposed role in viral replication, HRSV MTase holds promise as a potential antiviral target. Further biological validation of HRSV MTase could facilitate the discovery of novel HRSV antivirals targeting MTase enzyme activity.